The role of bile acid-activated receptor TGR5 in inflammation and liver diseases

Hongyan Xiang1, Huanyu Xiang1, Shuyun Wang1

  • 1Department of Geriatrics, Chongqing General Hospital, Chongqing University, Chongqing, China.

PubMed

Insights

Takeda G-protein-coupled receptor 5 (TGR5) is a bile acid receptor crucial for liver health. Targeting TGR5 shows promise for treating chronic liver diseases by modulating inflammation and metabolism.

Area of Science:

  • Hepatology and Gastroenterology
  • Immunology
  • Metabolic Diseases

Background:

  • Takeda G-protein-coupled receptor 5 (TGR5) is a bile acid receptor with functions beyond bile acid homeostasis.
  • TGR5 activation influences metabolic disorders and inflammatory responses via multiple mechanisms.
  • The receptor is widely expressed in liver cells, highlighting its central role in hepatic physiology and pathology.

Purpose of the Study:

  • To review the involvement of TGR5 in diverse liver diseases.
  • To summarize TGR5's regulatory roles in immune cells and inflammatory pathways.
  • To evaluate TGR5 as a therapeutic target for chronic liver conditions.

Main Methods:

  • Literature review consolidating current evidence on TGR5 in liver pathologies.
  • Summary of TGR5's regulatory functions in immune and inflammatory pathways.
  • Analysis of TGR5's therapeutic potential and future research directions.

Main Results:

  • TGR5 is implicated in metabolic dysfunction-associated steatohepatitis, cholestatic diseases, liver fibrosis, and hepatocellular carcinoma.
  • TGR5 modulates immune cell function and inflammatory signaling.
  • The receptor plays a pivotal role in regulating liver metabolism and inflammation.

Conclusions:

  • TGR5 is a promising therapeutic target for chronic liver diseases due to its role in inflammation and metabolism.
  • Future research should focus on developing tissue-specific TGR5 agonists for enhanced efficacy and reduced side effects.
  • Further elucidation of TGR5's dual roles in hepatocarcinogenesis is necessary for safe clinical application.

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
670
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.3K
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.5K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.9K
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
861
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
17.7K